Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD, MS discuss “Hepatitis C Treatment Initiation Among US Medicaid Enrollees,” by Kapadia SN, Zhang H, Gonzalez CJ, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2327326.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial,” by Hanauer S, Liedert B, Balser S, et al. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):816-825. Epub 2021 Aug 11.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Association of Proton Pump Inhibitor Use with Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study,” by Mehta R, Kochra B, Zhou Z, et al. Gastroenterology 2023; 165: 564-72.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial,” by Feagan BG, Sands BE, Sandborn WJ, et al. Lancet Gastroenterol Hepatol. 2023; 8: 307-20.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement from the American College of Physicians (Version 2),” by Qaseem A, Harrod CS, Crandall CJ, et al. Annals of Internal Medicine [2023; 176: 1092-1100].

Philip Schoenfeld, MD, MSEd, MSc (Epi), Philip Okafor, MD, MPH, and Linda Nguyen, MD discuss “A Randomized Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis,” by Zheng T, BouSaba J, Taylor A et al. Clinical Gastroenterology and Hepatology [2023 Jul 22;S1542-3565(23)00543-8].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swati Patel, MD, MS discuss “Varied Trainee Competence in Cold Snare Polypectomy - Results of the COMPLETE Randomized Controlled Trial,” by Kaltenbach T, Patel SG, Nguyen-Vu T, Malvar C, Keswani RN, Hall M, Aagaard E, Asokkumar R, Chin YK, Hammad H, Rastogi A, Shergill A, Simon V, Soetikno A, Soetikno R, Wani S. Am J Gastroenterol. [2023 Jun 13].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jeffrey Lee, MD, MPH discuss “Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard?” by Corley DA, Jensen CD, Chubak J, Schottinger JE, Halm EA, Udaltsova N. Gastroenterology. [2023 Sep;165(3):784-787.e4].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Nicole Rich, MD, MSCS discuss “A randomized trial of albumin infusions in hospitalized patients with cirrhosis,” by China L, Freemantle N, Forrest E et al. NEJM [2021; 384: 808-817].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Shria Kumar, MD, MSCE discuss “Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults,” by Calderwood AH, Tosteson TD, Wang Q, et al. JAMA Intern Med. [2023 May 1;183(5):426-34].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jennifer Kolb, MD, MS discuss “One-food versus six-food elimination diet therapy for the treatment of eosinophilic esophagitis: a multicenter, randomized, open-label trial,” by Kliewer K, Gonsalves N, Dellon E, et al. Lancet Gastro Hepatol [2023;8:408-21].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial,” Gearry R, Fukudo S, Barbara G, et al. Am J Gastroenterol [2023; 118: 1058-68].

Yichin Fu, MD; Sonali Paul, MD, MS discuss “Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial,” by Verrastro O, Panunzi S, Castagneto-Gissey L, et al. Lancet [2023 May 27;401(10390):1786-1797].

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Real-World Compliance with the 2020 US Multi-Society Task Force on Colorectal Cancer Polypectomy Surveillance Guidelines: An Observational Study,” by Dong J, Wang LF, Ardolino E, Feuerstein J. Gastrointest Endosc [2023; 97:350-56].

Rahul Dalal, MD, MPH and Jessica Allegretti, MD, MPH discuss “Upadacitinib Induction and Maintenance Therapy for Crohn's Disease,” by Loftus EV Jr, Panés J, Lacerda AP, Peyrin-Biroulet L, et al. N Engl J Med [2023 May 25;388(21):1966-1980].

Kristin Burke, MD, MPH and Bharati Kochar, MD, MS discuss “Vedolizumab for the Treatment of Chronic Pouchitis,” by Travis S, Silverberg MS, Danese S, et al for the EARNEST Study Group. N Engl J Med [2023 Mar 30;388(13):1191-1200].

Jacqueline Gaulin and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Response-Guided Therapy with Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Validation Study of 2021 AASLD Practice Guideline for SBP,” by Yim HJ, Kim TH, Suh SJ, et al. Am J Gastroenterol [2023; 118: 654-63].

Jacqueline Gaulin and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “AGA-ACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation,” by Chang L, Chey WD, Imdad A, et al. Am J Gastroenterol [2023; 118: 936-54].

Jeffrey Lee, MD, MPH and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Impact of a Scalable Training Program on the Quality of Colonoscopy Performance and Risk of Post-Colonoscopy Colorectal Cancer,” by Corley DA, Jensen CD, Lee JK, et al. Gastrointest Endosc [2023; In Press].

Philip Okafor, MD, MPH and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Frequency of Use and Outcomes in Individuals Older than 75 Years,” by El Halabi J, Burke CA, Hariri E, et al. JAMA Internal Medicine [2023; 183: 513-19].

Jennifer Kolb, MD, MS and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Comparison of Over-the-Scope Clips to Standard Endoscopic Treatment as the Initial Treatment in Patients With Bleeding From a Nonvariceal Upper Gastrointestinal Cause: A Randomized Controlled Trial,” by Lau JYW, Li R, Tan C et al. Ann Intern Med [2023 Apr;176(4):455-462].

Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discusses “Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis,” by Louvet A, Labreuche J, Dao T, et al. [JAMA 2023; 329 (18): 1558-66].

Shria Kumar, MD, MSCE and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Effect of Disposable Elevator Cap Duodenoscopes on Persistent Microbial Contamination and Technical Performance of Endoscopic Retrograde Cholangiopancreatography: The ICECAP Randomized Clinical Trial,” by Forbes N, Elmunzer BJ, Allain T, et al. JAMA Intern Med [2023;183(3):191-200].

Bharati Kochar, MD, MS and Editor-in-Chief Philip Schoenfeld, MD, MSEd discuss “Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn’s disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial,” by Sands BE, Irving PM, Hoops T, et al. Lancet [2022;399(10342):2200-2211].

Jessica Allegretti, MD, MPH and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis,” by Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Toruner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S. N Engl J Med [2019 Sep 26;381(13):1215-1226].